ArticlePlastic surgery (Oakville, Ont.)2021

Evaluation of Intra-Lesional Interleukin 2 for the Treatment of In-Transit Melanoma Disease: L'évaluation de l'interleukine-2 intralésionnelle pour traiter les mélanomes en transit.

Beatriz Lopez-Obregon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.